Cytosorbents Receives Nasdaq Delisting Notice for Low Market Value
CTSO sits 23% above its 52-week low of $0.35.
Summary
Cytosorbents Corp received a Nasdaq notice for non-compliance with the minimum market value rule, initiating a 180-day period to regain listing compliance.
Key Events · Corporate Governance and Compliance · CTSO
-
Nasdaq Non-Compliance Notice
Cytosorbents received a notice from Nasdaq for failing to meet the minimum $35 million Market Value of Listed Securities (MVLS) requirement.
-
180-Day Compliance Period
The company has 180 calendar days, until December 28, 2026, to regain compliance by having its market value exceed $35 million for at least 10 consecutive business days.
-
Delisting Risk Heightened
While not an immediate delisting, this formal notice underscores the urgency of the previously announced reverse stock split, which aims to boost the share price and market value to avoid delisting. Shareholders are scheduled to vote on this reverse split on August 13, 2026.
Analysis · CTSO · Industrial Applications And Services
Cytosorbents Corp received an official notice from Nasdaq for failing to meet the minimum $35 million Market Value of Listed Securities (MVLS) requirement. This formalizes the delisting risk previously indicated by the proposed reverse stock split, making the upcoming shareholder vote on August 13, 2026, even more critical. The company has until December 28, 2026, to regain compliance, which is essential for maintaining its Nasdaq listing and attracting institutional investment.
At the time of this filing, CTSO was trading at $0.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $27M. The 52-week trading range was $0.35 to $1.22. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.